Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty, Bone graft & orthobiologics.
All companies · Product and company coverage
In 2025, Xenco Medical reported engagement with 5 surgeons and other clinicians in the states MedaRep covers, worth $20K in consulting, speaking, meals and travel for its device products, the most in Florida ($7,500 to 1). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Florida ($7,500, 1 engaged), California ($7,350, 2 engaged), Colorado ($2,400, 1 engaged), Missouri ($2,400, 1 engaged).
In the last ten years FDA made 8 decisions for Xenco Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2019 (2). The latest was on 2025-01-29.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 9 |
| Cervical fusion & disc arthroplasty | 8 |
| Bone graft & orthobiologics | 2 |
| CancelleX Porous Titanium Lumbar Interbody Device |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Xenco Medical.